{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:47:11Z","timestamp":1783093631293,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014592","name":"Insulet Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.diabres.2024.111597","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T23:02:39Z","timestamp":1708988559000},"page":"111597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-3064","authenticated-orcid":false,"given":"Alexandros L.","family":"Liarakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebras","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.J.","family":"Crabtree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalantha","family":"Leelarathna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufyan","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masud","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2741-9841","authenticated-orcid":false,"given":"Erneda","family":"Gatdula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser W","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Lumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eswari","family":"Chinnasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4424-355X","authenticated-orcid":false,"given":"Robert E.J.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma G.","family":"Wilmot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2024.111597_b0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","article-title":"Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases","volume":"262","author":"Larsson","year":"2018","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.diabres.2024.111597_b0010","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.diabres.2024.111597_b0015","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111597_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.2014.16107","article-title":"Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality","volume":"313","author":"Orchard","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2024.111597_b0025","unstructured":"National Institute for Health and Care Excellence (NICE) Guideline on Type 1 Diabetes in adults: diagnosis and management. Available at: https:\/\/www.nice.org.uk\/guidance\/ng17 [accessed 5 January 2024]."},{"key":"10.1016\/j.diabres.2024.111597_b0030","unstructured":"National Diabetes Audit 2021-2022, Type 1 Diabetes - Overview. Available at: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-diabetes-audit-type-1-diabetes\/nda-type-1-2021-22-overview [accessed 5 January 2024]."},{"issue":"2","key":"10.1016\/j.diabres.2024.111597_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.diabres.2024.111597_b0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1464-5491.2008.02486.x","article-title":"Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion","volume":"25","author":"Pickup","year":"2008","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111597_b0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12020-016-1039-x","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis","volume":"55","author":"Benkhadra","year":"2017","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.diabres.2024.111597_b0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1089\/dia.2016.0239","article-title":"Impact of the Omnipod","volume":"18","author":"Polonsky","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2024.111597_b0055","doi-asserted-by":"crossref","first-page":"e14944","DOI":"10.1111\/dme.14944","article-title":"Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review","volume":"40","author":"Speight","year":"2023","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.diabres.2024.111597_b0060","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00125-021-05413-7","article-title":"Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland","volume":"64","author":"Jeyam","year":"2021","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2024.111597_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/dia.2009.0080","article-title":"Attitudes towards insulin pump therapy among adolescents and young people","volume":"12","author":"Seereiner","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2024.111597_b0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13300-010-0004-6","article-title":"The OmniPod Insulin Management System: the latest innovation in insulin pump therapy","volume":"1","author":"Zisser","year":"2010","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.diabres.2024.111597_b0075","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/193229681300700425","article-title":"Comparative dose accuracy of durable and patch insulin infusion pumps","volume":"7","author":"Jahn","year":"2013","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.diabres.2024.111597_b0080","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/1932296814543946","article-title":"Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies","volume":"8","author":"Borot","year":"2014","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.diabres.2024.111597_b0085","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/1932296814548216","article-title":"Insulin pump (dose-to-dose) accuracy: what does it mean and when is it important?","volume":"8","author":"Zisser","year":"2014","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"10.1016\/j.diabres.2024.111597_b0090","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/dia.2013.0016","article-title":"Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time","volume":"15","author":"Luijf","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.diabres.2024.111597_b0095","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/dme.13412","article-title":"Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes","volume":"34","author":"Leelarathna","year":"2017","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111597_b0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2337\/cd20-0022","article-title":"Improved glycemic control following transition to tubeless insulin pump therapy in adults with type 1 diabetes","volume":"39","author":"Mehta","year":"2021","journal-title":"Clin Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2024.111597_b0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1370\/afm.842","article-title":"Development of a brief diabetes distress screening instrument","volume":"6","author":"Fisher","year":"2008","journal-title":"Ann Fam Med"},{"issue":"7","key":"10.1016\/j.diabres.2024.111597_b0110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/diacare.17.7.697","article-title":"Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia","volume":"17","author":"Gold","year":"1994","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2024.111597_b0115","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2024.111597_b0120","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1932296816638674","article-title":"Efficacy of the Omnipod insulin management system on glycemic control in patients with type 1 diabetes previously treated with multiple daily injections or continuous subcutaneous insulin infusion","volume":"10","author":"Layne","year":"2016","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"10.1016\/j.diabres.2024.111597_b0125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S2213-8587(17)30217-6","article-title":"Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial","volume":"5","author":"Beck","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.diabres.2024.111597_b0130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/pedi.12658","article-title":"Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German\/Austrian DPV registry","volume":"19","author":"Danne","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2024.111597_b0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13300-023-01366-9","article-title":"Improvements in glycemic outcomes in 4738 children, adolescents, and adults with type 1 diabetes initiating a tubeless insulin management system","volume":"14","author":"Aleppo","year":"2023","journal-title":"Diabetes Ther"},{"issue":"6","key":"10.1016\/j.diabres.2024.111597_b0140","doi-asserted-by":"crossref","first-page":"e14420","DOI":"10.1111\/dme.14420","article-title":"Canadian real-world outcomes of Omnipod initiation in people with type 1 diabetes (COPPER study): Evidence from the LMC diabetes registry","volume":"38","author":"Brown","year":"2021","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.diabres.2024.111597_b0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/dia.2020.0675","article-title":"Declining frequency of acute complications associated with tubeless insulin pump use: Data from 2,911 patients in the German\/Austrian Diabetes Patienten Verlaufsdokumentation registry","volume":"23","author":"Biester","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.diabres.2024.111597_b0150","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/dme.12869","article-title":"Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes","volume":"32","author":"Beato-V\u00edbora","year":"2015","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.diabres.2024.111597_b0155","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/dme.13367","article-title":"Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control","volume":"34","author":"Anyanwagu","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2024.111597_b0160","unstructured":"National Institute for Health and Care Excellence (NICE) technology appraisal guidance (TA943) on hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. Available at: https:\/\/www.nice.org.uk\/guidance\/ta943 [accessed 13 February 2024]."},{"issue":"6","key":"10.1016\/j.diabres.2024.111597_b0165","doi-asserted-by":"crossref","first-page":"e2381","DOI":"10.1210\/clinem\/dgac047","article-title":"Insulin pump-related inpatient admissions in a national sample of youth with type 1 diabetes","volume":"107","author":"Everett","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.diabres.2024.111597_b0170","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/dom.14498","article-title":"Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures","volume":"23","author":"Thomas","year":"2021","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:29:21Z","timestamp":1759174161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"alternative-id":["S0168822724000810"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111597","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111597"}}